US Stock MarketDetailed Quotes

STAA Staar Surgical

Watchlist
  • 17.500
  • -0.190-1.07%
Close Feb 28 16:00 ET
  • 17.510
  • +0.010+0.06%
Post 20:01 ET
863.19MMarket Cap-42.68P/E (TTM)

About Staar Surgical Company

STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Company Profile

SymbolSTAA
Company NameStaar Surgical
Listing DateOct 26, 1990
Founded1982
CEOMr. Stephen C. Farrell
MarketNASDAQ
Employees1211
Fiscal Year Ends12-26
Address25510 Commercentre Drive
CityLake Forest
ProvinceCalifornia
CountryUnited States of America
Zip Code92630
Phone1-626-303-7902

Company Executives

  • Name
  • Position
  • Salary
  • Stephen C. Farrell
  • Director, President and Chief Executive Officer
  • 294.87K
  • Dr. Magda Michna
  • Chief Clinical, Regulatory, and Medical Affairs Officer
  • --
  • Scott D. Barnes
  • Chief Medical Officer
  • 2.48M
  • Patrick F. Williams
  • Vice President, Chief Financial Officer and Principal Accounting Officer
  • 2.82M
  • Warren Foust
  • Chief Operating Officer
  • 3.25M
  • Keith Holliday
  • Chief Technology Officer
  • 2.41M
  • Dr. Elizabeth Yeu, M.D.
  • Chairman of the Board
  • 249.99K
  • Wei Jiang
  • Director
  • --
  • Aimee S. Weisner
  • Independent Director
  • 259.96K
  • Wei Jiang
  • Independent Director
  • --
  • Lilian Zhou
  • Independent Director
  • 99.69K
  • Arthur C. Butcher
  • Independent Director
  • --
  • Nathaniel Sisitsky
  • General Counsel and Corporate Secretary
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More